Scholarlink

<p>Immune dysregulation and scar tissue formation following traumatic spinal cord injury (SCI) result in the generation of a microenvironment that significantly inhibits nerve regeneration and functional recovery. Continuous drug delivery across the dura, with minimal damage, and modulation of this inhibitory microenvironment pose substantial challenges in SCI treatment. This study fabricated a pH-responsive immunomodulatory microneedle (MN) patch by incorporating zeolitic imidazolate framework-8 (Zif-8) nanoparticles loaded with chondroitinase ABC (ChABC) into a gelatin methacrylate (GelMA) hydrogel (Z@C-MN). As the patch progressively degraded, this system continuously released Zn<sup>2+</sup> and ChABC in a pH-responsive manner to facilitate in situ SCI repair. In vitro, Z@C-MN can down-regulate macrophage inflammatory responses, promote axon extension, and differentiate neural stem cells into neurons. In vivo, Z@C-MN reduced the inflammatory microenvironment in an injury model and promoted angiogenesis in a rat SCI model. In addition, it promoted axonal regeneration and neurogenesis by inhibiting nerve scar formation and regulating CD4<sup>+</sup> T cell transformation. These effects contributed to the recovery of motor and neurological functions. Thus, this drug delivery system offers a highly efficient, transdural, and continuous-release multifunctional platform for patients with SCI.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impeding glial scarring hyperplasia and activating axon neogenesis via immunomodulatory microneedle patch for spinal cord repair

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月19日

查看全文
  • Tao Zhou,
  • Yajing Lin,
  • Ying Wang,
  • Lin Lin,
  • Jingtong Li,
  • Ning Tang,
  • Yingji Mao,
  • Pinghui Zhou

摘要

Immune dysregulation and scar tissue formation following traumatic spinal cord injury (SCI) result in the generation of a microenvironment that significantly inhibits nerve regeneration and functional recovery. Continuous drug delivery across the dura, with minimal damage, and modulation of this inhibitory microenvironment pose substantial challenges in SCI treatment. This study fabricated a pH-responsive immunomodulatory microneedle (MN) patch by incorporating zeolitic imidazolate framework-8 (Zif-8) nanoparticles loaded with chondroitinase ABC (ChABC) into a gelatin methacrylate (GelMA) hydrogel (Z@C-MN). As the patch progressively degraded, this system continuously released Zn2+ and ChABC in a pH-responsive manner to facilitate in situ SCI repair. In vitro, Z@C-MN can down-regulate macrophage inflammatory responses, promote axon extension, and differentiate neural stem cells into neurons. In vivo, Z@C-MN reduced the inflammatory microenvironment in an injury model and promoted angiogenesis in a rat SCI model. In addition, it promoted axonal regeneration and neurogenesis by inhibiting nerve scar formation and regulating CD4+ T cell transformation. These effects contributed to the recovery of motor and neurological functions. Thus, this drug delivery system offers a highly efficient, transdural, and continuous-release multifunctional platform for patients with SCI.

Graphical Abstract